MARATTO

article · Chemistry

Benzimidazole Derivatives: A Review of Advances in Synthesis, Biological Potential, Computational Modelling, and Specialized Material Functions

20258 citationsOpen accessUniversity of Tunis El Manar

Abstract

Benzimidazole derivatives are a privileged family of heterocyclic compounds that have remarkable structural diversity and find various pharmacological and industrial applications. In this article, we report on their synthetic procedures, ranging from classic condensation methodologies to modern green chemistry methodologies (microwave-assisted methods and catalyst-free methods). The biological significance of these derivatives is discussed, and their anticancer, antimicrobial, anti-inflammatory, antioxidant, antiparasitic, antiviral, antihypertensive, antidiabetic, and neuroprotective activities are reported. This article also reviews recent industrial applications, with special reference to hydrogen storage and environmental sustainability. The latest computational techniques, such as density functional theory (DFT), molecular docking, and molecular dynamics simulation, are particularly emphasized because they can be instrumental in understanding structure–activity relationships and rational drug design. In summary, the present review describes the importance of new benzimidazole derivatives, which are considered a different class of multitarget agents in medicinal chemistry and computational drug design.

Research topics

  • Synthesis and biological activity
  • Multicomponent Synthesis of Heterocycles
  • Microwave-Assisted Synthesis and Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/chemistry8010001

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.